Evidence map›Paper›PMID 37904175›Full record

ArticleGenome medicine2023

Bacterial genome-wide association study substantiates papGII of Escherichia coli as a major risk factor for urosepsis.

Aline Cuénod, Jessica Agnetti, Helena M B Seth-Smith, Tim Roloff, Denise Wälchli, Dimitri Shcherbakov, Rashid Akbergenov, Sarah Tschudin-Sutter, Stefano Bassetti, Martin Siegemund and 6 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Is Virulence GeneInfectious disease reports · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Molecular Characterization of High and Low VirulentInfection and drug resistance · 2024
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 4 countries.

Aline CuénodApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland. aline.cuenod@mcgill.ca.ORCID 0000-0002-8522-6134
Jessica AgnettiApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Helena M B Seth-SmithApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Tim RoloffApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Denise WälchliApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Dimitri ShcherbakovInstitute for Medical Microbiology, University of Zurich, Zurich, Switzerland.
Rashid AkbergenovInstitute for Medical Microbiology, University of Zurich, Zurich, Switzerland.
Sarah Tschudin-SutterInfectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland.
Stefano BassettiDivision of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Martin SiegemundDepartment of Clinical Research, University of Basel, Basel, Switzerland.
Christian H NickelEmergency Department, University Hospital Basel and University of Basel, Basel, Switzerland.
Jacob Moran-GiladDepartment of Health Policy and Management, School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Timothy G KeysDepartment of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
Valentin PflügerMabritec AG, Riehen, Switzerland.
Nicholas R ThomsonParasites and Microbes, Wellcome Trust Sanger Institute, Hinxton, UK.
Adrian EgliApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland. aegli@imm.uzh.ch.
University of Basel · CHUniversity of Zurich · CHSIB Swiss Institute of Bioinformatics · CHBen-Gurion University of the Negev · ILETH Zurich · CHUniversity Hospital of Basel · CHUniversity of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUrinary tract infections (UTIs) are among the most common bacterial infections worldwide, often caused by uropathogenic Escherichia coli. Multiple bacterial virulence factors or patient characteristics have been linked separately to progressive, more invasive infections. In this study, we aim to identify pathogen- and patient-specific factors that drive the progression to urosepsis by jointly analysing bacterial and host characteristics.

methodsWe analysed 1076 E. coli strains isolated from 825 clinical cases with UTI and/or bacteraemia by whole-genome sequencing (Illumina). Sequence types (STs) were determined via srst2 and capsule loci via fastKaptive. We compared the isolates from urine and blood to confirm clonality. Furthermore, we performed a bacterial genome-wide association study (bGWAS) (pyseer) using bacteraemia as the primary clinical outcome. Clinical data were collected by an electronic patient chart review. We concurrently analysed the association of the most significant bGWAS hit and important patient characteristics with the clinical endpoint bacteraemia using a generalised linear model (GLM). Finally, we designed qPCR primers and probes to detect papGII-positive E. coli strains and prospectively screened E. coli from urine samples (n = 1657) at two healthcare centres.

resultsOur patient cohort had a median age of 75.3 years (range: 18.00-103.1) and was predominantly female (574/825, 69.6%). The bacterial phylogroups B2 (60.6%; 500/825) and D (16.6%; 137/825), which are associated with extraintestinal infections, represent the majority of the strains in our collection, many of which encode a polysaccharide capsule (63.4%; 525/825). The most frequently observed STs were ST131 (12.7%; 105/825), ST69 (11.0%; 91/825), and ST73 (10.2%; 84/825). Of interest, in 12.3% (13/106) of cases, the E. coli pairs in urine and blood were only distantly related. In line with previous bGWAS studies, we identified the gene papGII (p-value < 0.001), which encodes the adhesin subunit of the E. coli P-pilus, to be associated with 'bacteraemia' in our bGWAS. In our GLM, correcting for patient characteristics, papGII remained highly significant (odds ratio = 5.27, 95% confidence interval = [3.48, 7.97], p-value < 0.001). An independent cohort of cases which we screened for papGII-carrying E. coli at two healthcare centres further confirmed the increased relative frequency of papGII-positive strains causing invasive infection, compared to papGII-negative strains (p-value = 0.033, chi-squared test).

conclusionsThis study builds on previous work linking papGII with invasive infection by showing that it is a major risk factor for progression from UTI to bacteraemia that has diagnostic potential.

Indexed as

BacteremiaEscherichia coli InfectionsSepsisUrinary Tract InfectionsUropathogenic Escherichia coliAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsFemaleGenome-Wide Association StudyHumansMaleMiddle AgedRisk FactorsAnti-Bacterial AgentsVirulence FactorsbGWASEscherichia coliInvasivenesspapGIIUrinary tract infection

Identifiers

PMID37904175
PMCPMC10614358
OpenAlexW4388021725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.